LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Spine/NewVert’s Octopus Passes Initial Test
Spine

NewVert’s Octopus Passes Initial Test

August 20, 2012 2 min read Premium comments

Advertisement

NewVert’s Octopus Passes Initial Test
Courtesy of NewVert Ltd.
Secondary

The initial biomechanical testing phase for NewVert’s Octopus Spinal Annular Repair System (OSA) has been successfully completed, according to a company press release. OSA is a deformable implant composed of nitinol, a super-elastic shape-memory alloy capable of providing mechanical support to the annular spinal tissues during post-implantation healing. The product is designed to repair the annulus following discectomy procedures and, hopefully, reduce the risk of costly re-operations. Developers say it is intended to provide a stable platform for tissue healing following a lumbar discectomy.

NewVert, Ltd is located in Netanya, Israel and The Institute of Orthopaedic Research and Biomechanics, of Ulm, Germany, performed the testing. Hagay Drori, CEO, of NewVert Ltd., commented on the results of the evaluations. “We are thrilled to have reached this important development milestone. Octopus successfully completed the initial biomechanical testing phase, simulating spinal annular repair during ‘worst case’ biomechanical loading scenarios, ” according to the July 30 press release.

Company officials report that, for managing lumbar herniation, there are an estimated 480, 000 discectomy procedures performed each year in the U.S. According to Drori, lumbar discectomy has been criticized in the medical literature for producing inconsistent results. The most recent data from Spine Patient Outcomes Research Trial reported an overall re-herniation rate of 6% requiring repeat surgery. Surgeons have estimated that, following discectomy surgery, approximately 20% to 40% of patients report recurring back pain and 5% to 15% present with recurrent disc herniation.

Surgeons have noted re-operation rates of 21%. Drori says that the rate of recurrent herniation is dependent on whether the discectomy was “conservative” or “aggressive.” Aggressive discectomy can accelerate degenerative processes, be a source of back pain and cause a relapse in symptoms. Conservative discectomy can potentially cause less operative pain, but it is associated with a higher recurrent herniation rate.

Drori says that the recurrent herniation rate of conservative discectomy is 5-18%, while the aggressive discectomy recurrent herniation rate ranges from 2-10%. The total procedure cost for managing a lumbar herniation he estimates to be $43, 118 per case, with an annual total patient population cost of over $20 billion. Hamid Sharim, M.D. and Roey Shafrir founded NewVert in 2010. It is a privately held development stage medical device company focused on minimally invasive spinal repair solutions.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy